{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:25:40Z","timestamp":1790436340942,"version":"4.1.0"},"reference-count":39,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["278001972"],"award-info":[{"award-number":["278001972"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>For many years, the biology of glycosphingolipids was elucidated with the help of glucosylceramide synthase (GCS) inhibitors such as 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP). Additionally, PDMP gained interest because of its chemosensitizing effects. Several studies have successfully combined PDMP and anti-cancer drugs in the context of cancer therapy. However, the mechanism of action of PDMP is not fully understood and seems to go beyond glycolipid inhibition. Here, we used a functionalized sphingosine analogue (pacSph) to investigate the acute effects of PDMP on cellular sphingolipid distribution and found that PDMP, but not other GCS inhibitors, such as ND-DNJ (also called Miglustat), induced sphingolipid accumulation in lysosomes. This effect could be connected to defective export from lysosome, as monitored by the prolonged lysosomal staining of sphingolipids as well as by a delay in the metabolic conversion of the pacSph precursor. Additionally, other lipids such as lysobisphosphatidic acid (LBPA) and cholesterol were enriched in lysosomes upon PDMP treatment in a time-dependent manner. We could further correlate early LBPA enrichment with dissociation of the mechanistic target of rapamycin (mTOR) from lysosomes followed by nuclear translocation of its downtream target, transcription factor EB (TFEB). Altogether, we report here a timeline of lysosomal lipid accumulation events and mTOR inactivation arising from PDMP treatment.<\/jats:p>","DOI":"10.3390\/ijms22137065","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T10:03:19Z","timestamp":1625047399000},"page":"7065","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The Glucosylceramide Synthase Inhibitor PDMP Causes Lysosomal Lipid Accumulation and mTOR Inactivation"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9344-7714","authenticated-orcid":false,"given":"Pia","family":"Hartwig","sequence":"first","affiliation":[{"name":"Heidelberg University Biochemistry Center (BZH), 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6862-0076","authenticated-orcid":false,"given":"Doris","family":"H\u00f6glinger","sequence":"additional","affiliation":[{"name":"Heidelberg University Biochemistry Center (BZH), 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,30]]},"reference":[{"key":"ref_1","first-page":"183","article-title":"Metabolic Effects of Inhibiting Glucosylceramide Synthesis with PDMP and Other Substances","volume":"26","author":"Radin","year":"1993","journal-title":"Adv. Lipid Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/jcp.1041500322","article-title":"Glycolipid Depletion Using a Ceramide Analogue (PDMP) Alters Growth, Adhesion, and Membrane Lipid Organization in Human A431 Cells","volume":"150","author":"Barbour","year":"1992","journal-title":"J. Cell. Physiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jcp.1041410316","article-title":"Effects of D-threo-PDMP, an Inhibitor of Glucosylceramide Synthetase, on Expression of Cell Surface Glycolipid Antigen and Binding to Adhesive Proteins by B16 Melanoma Cells","volume":"141","author":"Inokuchi","year":"1989","journal-title":"J. Cell. Physiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0014-4827(92)90392-L","article-title":"A Ceramide Analogue (PDMP) Inhibits Glycolipid Synthesis in Fish Embryos","volume":"198","author":"Fenderson","year":"1992","journal-title":"Exp. Cell Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bbrc.2014.12.019","article-title":"The Glucosylceramide Synthase Inhibitor PDMP Sensitizes Pancreatic Cancer Cells to MEK\/ERK Inhibitor AZD-6244","volume":"456","author":"Wang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Chatterjee, S., Alsaeedi, N., Hou, J., Bandaru, V.V.R., Wu, L., Halushka, M.K., Pili, R., Ndikuyeze, G., and Haughey, N.J. (2013). Use of a Glycolipid Inhibitor to Ameliorate Renal Cancer in a Mouse Model. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063726"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11010-011-1086-9","article-title":"1-Phenyl-2-Decanoylamino-3-Morpholino-1-Propanol (PDMP) Facilitates Curcumin-Induced Melanoma Cell Apoptosis by Enhancing Ceramide Accumulation, JNK Activation, and Inhibiting PI3K\/AKT Activation","volume":"361","author":"Yu","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00280-013-2318-3","article-title":"Bortezomib-Induced Apoptosis in Cultured Pancreatic Cancer Cells Is Associated with Ceramide Production","volume":"73","author":"Gong","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.4049\/jimmunol.167.7.3773","article-title":"Ceramide Mediates Tumor-Induced Dendritic Cell Apoptosis","volume":"167","author":"Kanto","year":"2001","journal-title":"J. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1083\/jcb.139.6.1411","article-title":"Ceramide Accumulation Uncovers a Cycling Pathway for the Cis-Golgi Network Marker, Infectious Bronchitis Virus M Protein","volume":"139","author":"Maceyka","year":"1997","journal-title":"J. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1021\/bi052104y","article-title":"D-Threo-1-Phenyl-2-Decanoylamino-3-Morpholino-1-Propanol Alters Cellular Cholesterol Homeostasis by Modulating the Endosome Lipid Domains","volume":"45","author":"Asami","year":"2006","journal-title":"Biochemistry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"126891","DOI":"10.1016\/j.bmcl.2019.126891","article-title":"The Ceramide Analogue N-(1-Hydroxy-3-Morpholino-1-Phenylpropan-2-Yl)Decanamide Induces Large Lipid Droplet Accumulation and Highlights the Effect of LAMP-2 Deficiency on Lipid Droplet Degradation","volume":"30","author":"Kato","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-17645-z","article-title":"Caveolin-1-Mediated Sphingolipid Oncometabolism Underlies a Metabolic Vulnerability of Prostate Cancer","volume":"11","author":"Vykoukal","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/cdd.2009.208","article-title":"Association of Fission Proteins with Mitochondrial Raft-like Domains","volume":"17","author":"Ciarlo","year":"2010","journal-title":"Cell Death Differ."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.yexcr.2016.11.011","article-title":"PDMP, a Ceramide Analogue, Acts as an Inhibitor of MTORC1 by Inducing Its Translocation from Lysosome to Endoplasmic Reticulum","volume":"350","author":"Ode","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1242\/jcs.051011","article-title":"MTOR Signaling at a Glance","volume":"122","author":"Laplante","year":"2009","journal-title":"J. Cell Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrg1879","article-title":"The Evolution of Phosphatidylinositol 3-Kinases as Regulators of Growth and Metabolism","volume":"7","author":"Engelman","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6710","DOI":"10.1128\/MCB.24.15.6710-6718.2004","article-title":"MTOR Is Essential for Growth and Proliferation in Early Mouse Embryos and Embryonic Stem Cells","volume":"24","author":"Murakami","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2967\/jnumed.111.089623","article-title":"MTOR Signaling, Function, Novel Inhibitors, and Therapeutic Targets","volume":"52","author":"Watanabe","year":"2011","journal-title":"J. Nucl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.12703\/P6-52","article-title":"MTOR and Lysosome Regulation","volume":"6","author":"Puertollano","year":"2014","journal-title":"F1000Prime Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1126\/science.1157535","article-title":"The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to MTORC1","volume":"320","author":"Sancak","year":"2008","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41420-020-0260-9","article-title":"How Does MTOR Sense Glucose Starvation? AMPK Is the Usual Suspect","volume":"6","author":"Leprivier","year":"2020","journal-title":"Cell Death Discov."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Yoon, M.S. (2017). The Role of Mammalian Target of Rapamycin (MTOR) in Insulin Signaling. Nutrients, 9.","DOI":"10.3390\/nu9111176"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"MTOR Signaling in Growth Control and Disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/emboj.2012.32","article-title":"A Lysosome-to-Nucleus Signalling Mechanism Senses and Regulates the Lysosome via MTOR and TFEB","volume":"31","author":"Settembre","year":"2012","journal-title":"EMBO J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1126\/science.aaf8310","article-title":"MTORC1 Activity Repression by Late Endosomal Phosphatidylinositol 3,4-Bisphosphate","volume":"356","author":"Marat","year":"2017","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ccell.2017.11.011","article-title":"MTORC2 Promotes Tumorigenesis via Lipid Synthesis","volume":"32","author":"Guri","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2174\/156800910791517172","article-title":"The MTOR Pathway: A New Target in Cancer Therapy","volume":"10","author":"Ciuffreda","year":"2010","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.trecan.2016.10.006","article-title":"MTOR Signaling Confers Resistance to Targeted Cancer Drugs","volume":"2","author":"Guri","year":"2016","journal-title":"Trends Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13578-020-00396-1","article-title":"MTOR Signaling Pathway and MTOR Inhibitors in Cancer: Progress and Challenges","volume":"10","author":"Zou","year":"2020","journal-title":"Cell Biosci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1021\/acschembio.5b00810","article-title":"Bifunctional Sphingosine for Cell-Based Analysis of Protein-Sphingolipid Interactions","volume":"11","author":"Haberkant","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gerl, M.J., Bittl, V., Kirchner, S., Sachsenheimer, T., Brunner, H.L., L\u00fcchtenborg, C., \u00d6zbalci, C., Wiedemann, H., Wegehingel, S., and Nickel, W. (2016). Sphingosine-1-Phosphate Lyase Deficient Cells as a Tool to Study Protein Lipid Interactions. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153009"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0022-2275(20)39895-3","article-title":"Structural and Stereochemical Studies of Potent Inhibitors of Glucosylceramide Synthase and Tumor Cell Growth","volume":"36","author":"Abe","year":"1995","journal-title":"J. Lipid Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0076-6879(00)11097-3","article-title":"Inhibitors of Glucosylceramide Synthase","volume":"311","author":"Shayman","year":"2000","journal-title":"Methods Enzymol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0022-2275(20)39966-1","article-title":"Effects of the Glucosphingolipid Synthesis Inhibitor, PDMP, on Lysosomes in Cultured Cells","volume":"35","author":"Rosenwald","year":"1994","journal-title":"J. Lipid Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1083\/jcb.201306041","article-title":"Where Is MTOR and What Is It Doing There?","volume":"203","author":"Betz","year":"2013","journal-title":"J. Cell Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1242\/jcs.146365","article-title":"TFEB at a Glance","volume":"129","author":"Napolitano","year":"2016","journal-title":"J. Cell Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1021\/cb4003442","article-title":"FluoQ: A Tool for Rapid Analysis of Multiparameter Fluorescence Imaging Data Applied to Oscillatory Events","volume":"8","author":"Stein","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Wickham, H. (2016). Ggplot2, Springer International Publishing. Use R!.","DOI":"10.1007\/978-3-319-24277-4"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/13\/7065\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:24:04Z","timestamp":1760163844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/13\/7065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,30]]},"references-count":39,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["ijms22137065"],"URL":"https:\/\/doi.org\/10.3390\/ijms22137065","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,30]]}}}